203 related articles for article (PubMed ID: 22942433)
1. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus.
Koga T; Ichinose K; Mizui M; Crispín JC; Tsokos GC
J Immunol; 2012 Oct; 189(7):3490-6. PubMed ID: 22942433
[TBL] [Abstract][Full Text] [Related]
2. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
[TBL] [Abstract][Full Text] [Related]
3. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
[TBL] [Abstract][Full Text] [Related]
4. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
Shui B; Xia W; Wen C; Ding X
J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
[TBL] [Abstract][Full Text] [Related]
5. Calcium/Calmodulin Kinase IV Controls the Function of Both T Cells and Kidney Resident Cells.
Ferretti AP; Bhargava R; Dahan S; Tsokos MG; Tsokos GC
Front Immunol; 2018; 9():2113. PubMed ID: 30333818
[TBL] [Abstract][Full Text] [Related]
6. Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.
Ichinose K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Arima K; Nakamura H; Obata Y; Yamamoto K; Origuchi T; Nishino T; Kawakami A; Tsokos GC
Arthritis Rheumatol; 2016 Apr; 68(4):944-52. PubMed ID: 26636664
[TBL] [Abstract][Full Text] [Related]
7. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
Ichinose K; Juang YT; Crispín JC; Kis-Toth K; Tsokos GC
Arthritis Rheum; 2011 Feb; 63(2):523-9. PubMed ID: 20954187
[TBL] [Abstract][Full Text] [Related]
8. Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis.
Du B; Fan X; Lei F; Zhang S; Li G; Xi X
Int Immunopharmacol; 2020 Mar; 80():106139. PubMed ID: 31978801
[TBL] [Abstract][Full Text] [Related]
9. The role of CaMK4 in immune responses.
Koga T; Kawakami A
Mod Rheumatol; 2018 Mar; 28(2):211-214. PubMed ID: 29252071
[TBL] [Abstract][Full Text] [Related]
10. CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.
Maeda K; Otomo K; Yoshida N; Abu-Asab MS; Ichinose K; Nishino T; Kono M; Ferretti A; Bhargava R; Maruyama S; Bickerton S; Fahmy TM; Tsokos MG; Tsokos GC
J Clin Invest; 2018 Aug; 128(8):3445-3459. PubMed ID: 29985166
[TBL] [Abstract][Full Text] [Related]
11. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
[TBL] [Abstract][Full Text] [Related]
12. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
14. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
Katsuyama E; Yan M; Watanabe KS; Narazaki M; Matsushima S; Yamamura Y; Hiramatsu S; Ohashi K; Watanabe H; Katsuyama T; Zeggar S; Yoshida N; Moulton VR; Tsokos GC; Sada KE; Wada J
J Immunol; 2017 Jun; 198(11):4268-4276. PubMed ID: 28438897
[TBL] [Abstract][Full Text] [Related]
16. CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses.
Scherlinger M; Li H; Pan W; Li W; Karino K; Vichos T; Boulougoura A; Yoshida N; Tsokos MG; Tsokos GC
Nat Commun; 2024 Jan; 15(1):840. PubMed ID: 38287012
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis.
Ichinose K; Rauen T; Juang YT; Kis-Toth K; Mizui M; Koga T; Tsokos GC
J Immunol; 2011 Dec; 187(11):5500-4. PubMed ID: 22031763
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of lupus nephritis by high sodium chloride related to activation of SGK1 pathway.
Yang X; Yao G; Chen W; Tang X; Feng X; Sun L
Int Immunopharmacol; 2015 Dec; 29(2):568-573. PubMed ID: 26474695
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
